Welcome to our dedicated page for Piermont Valley Acquisition SEC filings (Ticker: CMCAF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Capitalworks Emerging A (CMCAF) filings document SPAC-related material events for the issuer identified in recent records as Piermont Valley Acquisition Corp. The Form 8-K record covers shareholder voting matters, amendments to the company’s amended and restated memorandum and articles of association, business-combination deadline extensions, governance changes and capital-structure disclosures.
The filing record also identifies the issuer’s securities, including units, Class A ordinary shares and warrants exercisable for Class A ordinary shares. These disclosures frame the company as a blank-check issuer whose regulatory documents focus on shareholder approvals, board composition, security terms and the mechanics of continuing as a public acquisition vehicle.
Piermont Valley Acquisition Corp, a Cayman Islands SPAC, filed its annual report describing its status, risks and plans to complete a merger before March 3, 2027. The company has repeatedly extended its deadline and, after several large redemption rounds, now has 5,954,449 Class A shares and 1 Class B share outstanding.
The report highlights a pending business combination with Tigerless Health via a multi-step merger into a new Nevada holding company, where former Tigerless stockholders are expected to own a majority. As of March 31, 2026, the trust account is anticipated to be about $12.02 per public share, and if no deal is completed by the deadline the SPAC will liquidate and redeem public shares.
Terms include up to $100 million of stock-based earn-out for Tigerless holders tied to multi-year performance milestones and a targeted PIPE raise of at least $5 million, which is not yet committed. The filing also notes prior termination of a Lexasure transaction and the company’s 2024 delisting from Nasdaq after missing the 36‑month business combination window.
Piermont Valley Acquisition Corp entered into a definitive merger agreement to combine with Tigerless Health, creating a new public operating company ("Pubco"). The transactions use a two-step reorganization: Tigerless will merge into a Tigerless subsidiary, then a Tigerless subsidiary will merge into Piermont, leaving Tigerless and Piermont as subsidiaries of Pubco.
The agreement contemplates issuance of Pubco Class A and Class B shares to former Tigerless and Piermont securityholders, an earn-out program with a $100.0 million maximum payout across four annual tests (capped at $25.0 million per year), and a targeted PIPE financing of at least $5,000,000. Closing is expected in the second half of 2026 and is subject to shareholder approvals, SEC effectiveness of a Form S-4 registration statement, Nasdaq approval, customary conditions and possible termination dates of September 30, 2026 (extendable to December 31, 2026) under specified circumstances.
Tigerless Health, Inc., a New York-based Insurtech platform, has agreed to a definitive business combination with Piermont Valley Acquisition Corp., a publicly traded SPAC, valuing Tigerless Health at an enterprise value of approximately $280 million.
After closing, the combined company is expected to be renamed Tigerless AI Holdings, Inc. and listed on NASDAQ, with all existing Tigerless Health shareholders rolling 100% of their equity. The deal is intended to support continued investment in the company’s proprietary AI capabilities that help consumers understand and navigate insurance.
The boards of both companies have unanimously approved the transaction, which is expected to close in the second half of 2026, subject to shareholder and regulatory approvals and other customary closing conditions. Founder and CEO Zikang Wu and his management team are expected to continue leading the combined company.
Piermont Valley Acquisition Corp. reported a Board change. On February 24, 2026, director Brian Coad resigned from the company’s Board of Directors.
The company stated that Mr. Coad’s resignation was not due to any disagreement regarding its operations, policies, or practices.
Piermont Valley Acquisition Corp. held an extraordinary general meeting of shareholders on March 2, 2026, where an extension proposal was approved. A quorum of 5,950,000 Class A ordinary shares and one Class B ordinary share was represented. The proposal received 5,950,000 votes in favor, none against and one abstention. Because this proposal passed and quorum was present, a planned adjournment proposal was not put to a vote. In connection with the extension, 536 Class A ordinary shares were redeemed. After these redemptions, 5,954,419 Class A ordinary shares and one Class B ordinary share were outstanding. An amendment to the company’s Amended and Restated Memorandum and Articles of Association to implement the extension has been filed with the Cayman Islands Registrar of Companies.